Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Access to effective affordable contraception is critical for individual and public health. A wide range of hormonal contraceptives (HCs), which differ in composition, concentration of the progestin component, frequency of dosage, and method of administration, is currently available globally. However, the options are rather limited in settings with restricted economic resources that frequently overlap with areas of high HIV-1 prevalence. The predominant contraceptive used in sub-Saharan Africa is the progestin-only three-monthly injectable depot medroxyprogesterone acetate. Determination of whether HCs affect HIV-1 acquisition has been hampered by behavioral differences potentially confounding clinical observational data. Meta-analysis of these studies shows a significant association between depot medroxyprogesterone acetate use and increased risk of HIV-1 acquisition, raising important concerns. No association was found for combined oral contraceptives containing levonorgestrel, nor for the two-monthly injectable contraceptive norethisterone enanthate, although data for norethisterone enanthate are limited. Susceptibility to HIV-1 and other sexually transmitted infections may, however, be dependent on the type of progestin present in the formulation. Several underlying biological mechanisms that may mediate the effect of HCs on HIV-1 and other sexually transmitted infection acquisition have been identified in clinical, animal, and ex vivo studies. A substantial gap exists in the translation of basic research into clinical practice and public health policy. To bridge this gap, we review the current knowledge of underlying mechanisms and biological effects of commonly used progestins. The review sheds light on issues critical for an informed choice of progestins for the identification of safe, effective, acceptable, and affordable contraceptive methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190
Sex hormones and the immune response in humans
Bouman, A., Heineman, M. J., & Faas, M. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi008 · Cited by 1,131
How stress influences the immune response
Padgett, D. A., & Glaser, R. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00173-x · Cited by 1,059
Probiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907
Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends
Sedgh, G., Bearak, J., Singh, S., Bankole, A., Popinchalk, A., Ganatra, B., Rossier, C., Gerdts, C., Tunçalp, Ö., Johnson, B. R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30380-4 · Cited by 766
Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429 · cited 1×
“Sources of data include references (24, 25).”
Self-citationHIV/AIDS in Women: An Expanding Epidemic
Quinn, T. C., & Overbaugh, J. (2005) · Science · doi:10.1126/science.1112489 · Cited by 417
Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., & Hillier, S. L. (2003) · Clinical Infectious Diseases · doi:10.1086/375819 · Cited by 415
Busillo, J. M., & Cidlowski, J. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.005 · Cited by 339
Anukam, K. C., Osazuwa, E., Osemene, G. I., Ehigiagbe, F., Bruce, A. W., & Reid, G. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.08.008 · Cited by 276
Borgdorff, H., Gautam, R., Armstrong, S. D., Xia, D., Ndayisaba, G. F., van Teijlingen, N. H., Geijtenbeek, T. B. H., Wastling, J. M., & van de Wijgert, J. H. H. M. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.86 · Cited by 253
All progestins are not created equal
Stanczyk, F. Z. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.003 · Cited by 226 · cited 1×
“All other relative binding affinities and all other progestin biological activities in preclinical models were taken from references (32, 38).”
BackgroundPolis, C. B., Curtis, K. M., Hannaford, P. C., Phillips, S. J., Chipato, T., Kiarie, J. N., Westreich, D. J., & Steyn, P. S. (2016) · AIDS · doi:10.1097/qad.0000000000001228 · Cited by 196 · cited 1×
“(4) Increased infection with other viruses such as HSV-2.”
BackgroundSasagawa, S., Shimizu, Y., Kami, H., Takeuchi, T., Mita, S., Imada, K., Kato, S., & Mizuguchi, K. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.003 · Cited by 177
Kaunitz, A. M., Darney, P. D., Ross, D., Wolter, K. D., & Speroff, L. (2009) · Contraception · doi:10.1016/j.contraception.2009.02.005 · Cited by 123 · cited 1×
“Cmax concentrations of plasma MPA after DMPA-IM and DMPA-SC administration have not been compared in a head-to-head study, but they have been at 6 months to 2 years, where levels were measured just before the next injection (61).”
Ronacher, K., Hadley, K., Avenant, C., Stubsrud, E., Simons, S. S., Louw, A., & Hapgood, J. P. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.008 · Cited by 121
Self-citationFormation of Ethinyl Estradiol in Women during Treatment with Norethindrone Acetate
Chu, M. C., Zhang, X., Gentzschein, E., Stanczyk, F. Z., & Lobo, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0044 · Cited by 100
Altemus, M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00121-8 · Cited by 74
Chwalisz, K., Surrey, E., & Stanczyk, F. Z. (2012) · Reproductive Sciences · doi:10.1177/1933719112438061 · Cited by 58
Cited by
Ahmed, K., Baeten, J. M., Beksinska, M., Bekker, L.-G., Bukusi, E. A., Donnell, D., Gichangi, P. B., Heller, K. B., Hofmeyr, G. J., Justman, J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31288-7 · Cited by 299
Thomson, K. A., Hughes, J., Baeten, J. M., John-Stewart, G., Celum, C., Cohen, C. R., Ngure, K., Kiarie, J., Mugo, N., Heffron, R., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy113 · Cited by 298
Wessels, J. M., Felker, A. M., Dupont, H. A., & Kaushic, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035147 · Cited by 102
“This is an area of active research, particularly because the progestin-based injectable contraceptive DMPA is linked to increased HIV-1 susceptibility (Hapgood et al., 2018; Kaushic, 2009; Morrison et al., 2015; Polis et al., 2016).”
BackgroundSelf-citationMcCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J., & Jones, H. E. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000975 · Cited by 23
Kiweewa, F. M., Brown, E., Mishra, A., Nair, G., Palanee‐Phillips, T., Mgodi, N., Nakabiito, C., Chakhtoura, N., Hillier, S. L., Baeten, J. M., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25257 · Cited by 19
Metadata
- Authors
- Hapgood, J. P., Kaushic, C., & Hel, Z.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2018-01-04
- Volume
- 39
- Issue
- 1
- Pages
- 36-78
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2782051442
- Cited by
- 112
- References
- 21
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.